Prosecution Insights
Last updated: April 19, 2026

Peptinovo Biopharma, Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19204171 CHEMOTHERAPEUTIC PACLITAXEL BASED MICELLULAR NANOPARTICLES ESPINOSA, CLAUDIA EDILMA 1654 Non-Final OA May 09, 2025
18041289 PEPTIDES AND FORMULATIONS FOR CANCER TREATMENT NIEBAUER, RONALD T 1658 Non-Final OA Feb 10, 2023
17634975 PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER DABKOWSKI, ERINNE R 1654 Non-Final OA Feb 12, 2022

Managing Peptinovo Biopharma, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month